Renalyx Health Systems
Renalyx Health Systems is a Bengaluru-based medical device company developing indigenous AI-enabled hemodialysis machines, point-of-care CKD diagnostic devices, and a cloud-based Digital Nephrology Platform serving hospitals, dialysis centers, and primary healthcare providers in India.
- Company typePrivate
- Founded2012
- HeadquartersBengaluru, India
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Renalyx Health Systems does
Renalyx Health Systems Private Limited, founded in October 2012 in Bengaluru, India, is a medical device company developing indigenous hemodialysis and renal care technology. The company serves healthcare providers, hospitals, dialysis centers, primary care facilities, and nephrologists with an end-to-end renal care platform spanning early Chronic Kidney Disease (CKD) detection through acute and chronic dialysis treatment. Its product portfolio comprises the RxT21, an AI-based smart hemodialysis machine designed for Sustained Low Efficiency Dialysis (SLED) in ICU settings; the RxT17 PHC Dialysis Machine for primary healthcare ESRD treatment; ReachnCare, a point-of-care early CKD detection system using patented microalbumin/creatinine strips with cloud-based EMR generation; and a cloud-based Digital Nephrology Platform that automates dialysis workflows, reporting, and remote patient monitoring. The company holds CE marking, CDSCO Class C manufacturing licenses (held by both BEL and Lords Mark Industries), ISO 13485 certification, and DSIR R&D recognition.
The company generates revenue through three streams: medical device hardware sales (dialysis machines and diagnostic devices), recurring software/subscription services via the Digital Nephrology Platform, and consumables (dialysers and supplies). Distribution follows a hybrid OEM and channel model: Bharat Electronics Limited (BEL), a defense PSU, manufactures the RxT17 under license; Genworks handles pan-India distribution and servicing; Vinyas Innovative Technologies provides manufacturing services from Mysore; and Browndove supplies consumables. Pricing is quote-based for enterprise healthcare providers and is not publicly disclosed. Clinical validation has been conducted at hospitals including Narayana Hrudayalaya, St. John's Medical College, and Apollo Hospital Chennai. The company has been majority-owned (85%) by Lords Mark Industries since November 2025, operating as part of the Lord's Mark Group, with a Rs. 800 crore capital plan to establish 3 production units in Karnataka over 4 years.
Renalyx Health Systems firmographics
Firmographics- Name
- Renalyx Health Systems
- Legal name
- Renalyx Health Systems Private Limited
- Website
- https://renalyx.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Renalyx Health Systems is a Bengaluru-based medical device company developing indigenous AI-enabled hemodialysis machines, point-of-care CKD diagnostic devices, and a cloud-based Digital Nephrology Platform serving hospitals, dialysis centers, and primary healthcare providers in India.
- Ownership category
- akta.pro rank
Renalyx Health Systems industry classification
Industry- Product category
- Hemodialysis Medical Devices
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Hemodialysis Machines & Systems (HLAHAKAA)
- akta.pro secondary industries
- Renal Diagnostics & Monitoring (eGFR/Creatinine POC, Urine Analyzers, BP/Fluid Status) (HLAHAKAJ), Nephrology Telemedicine Platforms (HLALAGAI), Home Dialysis Equipment & Remote Monitoring (HLAHAKAG)
Keywords
Where Renalyx Health Systems is headquartered
LocationHeadquarters
- HQ city
- Bengaluru
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Renalyx Health Systems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Sale of hemodialysis machines (RxT17 and RxT21), point-of-care diagnostic devices, and related medical equipment to healthcare providers and hospitals.
- Software/Subscription Services: Digital Nephrology Platform providing cloud-based dialysis workflow automation, remote monitoring, and analytics services.
- Consumables: Dialysis consumables including dialysers and other supplies used during hemodialysis sessions through partnership with Browndove.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
Renalyx Health Systems product offering
Product offeringCore offering
Renalyx Health Systems designs, develops and manufactures indigenous hemodialysis machines (RxT17 and RxT21) along with a cloud-based Digital Nephrology Platform and the ReachnCare point-of-care CKD early detection system. The company provides an end-to-end renal care solution spanning early Chronic Kidney Disease detection, dialysis treatment for ESRD and ICU patients, and remote patient monitoring by qualified nephrologists.
Product overview
Renalyx Health Systems offers a comprehensive end-to-end renal care solution comprising four integrated products. The portfolio centers on the RxT21, the world's first indigenous AI-based SLED (Sustained Low Efficiency Dialysis) hemodialysis machine for ICU renal replacement therapy, complemented by the RxT17 PHC Dialysis Machine for primary healthcare ESRD treatment. The ReachnCare system provides early CKD detection using patented test strips with ACR analysis and a companion mobile app for disease management. All dialysis machines connect through the Digital Nephrology Platform, a cloud-based system that automates workflows, enables remote patient monitoring by nephrologists, and tracks operational metrics. The company operates as part of Lord's Mark Group following an 85% stake acquisition.
Differentiator
Problem solved
Functional benefit
Products and services
- RxT21 AI-Based Smart Hemodialysis Machine AI-powered Sustained Low Efficiency Dialysis (SLED) hemodialysis machine designed for renal replacement therapy in intensive care unit settings. Features AI-based monitoring, clinical connectivity, and remote vital statistics monitoring by qualified nephrologists, and is positioned for hospital ICUs and tertiary care centers treating patients with acute renal failure.
- RxT17 PHC Dialysis Machine Indigenously developed Primary Healthcare (PHC) hemodialysis machine for treating CKD stage-5 (ESRD) patients, with CE certification, color touchscreen display, audio-visual alarms and remote vital statistics monitoring by qualified nephrologists.
- ReachnCare CKD Early Detection System Point-of-care early CKD detection system combining patented Microalbumin and Creatinine test strips that produce an ACR reading with a mobile app that functions as a virtual assistant for stages 1-4 disease management, supports GP workflows, manages diabetes and hypertension, and generates cloud-based EMRs for primary care and rural use.
- Digital Nephrology Platform Cloud-based web system that automates dialysis workflows, auditing and reporting, and enables remote monitoring of dialysis machines and tracking of key metrics such as machine utilization, maintenance, staffing and consumables for healthcare providers operating dialysis units.
Quantifiable outcome
- Addressed rising demand for dialysis care driven by increasing End-Stage Renal Disease cases in India
- +1 more outcomes
Companies that use Renalyx Health Systems
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Renalyx Health Systems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
Renalyx Health Systems partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Bharat Electronics Limited (BEL)coreRenalyx is associated with Bharat Electronics for the manufacturing of RxT17 Hemodialysis machine. BEL obtained CDSCO license to manufacture the device. Renalyx is also joint technology partner for collaborative R&D.
- IIT KharagpurcoreRenalyx is associated with Department of Chemical Engineering and School of Medical Science and Technology for R&D in dialysis membrane. Jointly won Technology Innovation award for dialyser development.
- Vinyas Innovative TechnologiescoreRenalyx is associated with Vinyas Innovative Technologies for manufacturing services of medical products in their state-of-the-art facility located at Mysore.
- Genworks HealthcoreRenalyx is associated with Genworks for distribution, sales and servicing of Renalyx products across India.
- PESIT (PES College of Engineering)minorRenalyx is associated with PESIT Center of Research and Innovation for R&D in dialysis for rural CKD patients.
- BMSIT (BMS College of Engineering)minorRenalyx is associated with Innovation Center of Department of Medical Electronics for research in Point of Care devices for detection of early stage CKD.
- eHealth EnablersminorRenalyx is associated with eHealth Enablers, one of the first accelerators for Healthcare enabling startup companies.
- Swasthya Med-CminorRenalyx is associated with Swasthya Med-C, an association of Medical Electronics Devices Manufacturers with over 30 members forming a cluster ecosystem for medical electronics devices companies and startups.
Scale indicators4 records
Recent moves7 records
Expansion highlights7 records
Renalyx Health Systems competitors and assessment
Company assessmentBroad incumbents
- DaVita: One of the two largest dialysis service providers globally, operating thousands of outpatient dialysis centres. Overlaps with Renalyx on the demand side — DaVita-style providers are potential large-volume buyers of Renalyx's machines and platform.
- Fresenius Medical Care: Global leader in dialysis products and services, manufacturing hemodialysis machines, dialyzers and consumables while also operating the largest dialysis clinic network. Directly comparable to Renalyx on the hemodialysis hardware side and represents the dominant incumbent Renalyx must displace.
- B. Braun Avitum: Division of B. Braun that develops and supplies hemodialysis machines (Dialog+, Omni), dialyzers and therapy solutions globally. Directly comparable product portfolio to Renalyx's RxT17/RxT21 across hospital and clinic segments.
- Asahi Kasei Medical: Leading global supplier of dialysis membranes (dialyzers) and other renal-care consumables. Comparable to Renalyx on the renal consumables/materials side and represents a potential partnership or competitive overlap.
- Nipro Corporation: Japanese medical device company with a substantial renal care business producing dialyzers, hemodialysis machines and dialysis-related disposables. Comparable to Renalyx as a vertically integrated dialysis products competitor, particularly in Asia.
- Baxter International (Vantive / Kidney Care): Long-established dialysis products business (now being separated as Vantive) selling hemodialysis machines, PD systems and dialyzers globally. Renalyx advisor Dr. Prakash Keshaviah is a former Baxter VP R&D, underscoring direct technology overlap.
Regional players
- BPL Medical Technologies: Indian medical device company with a broad portfolio including patient monitoring and related equipment. Comparable as an India-based medical device manufacturer pursuing domestic and emerging-market hospital customers with indigenous products.
- Trivitron Healthcare: India-headquartered medical technology company offering a wide range of medical devices and diagnostic solutions across emerging markets. Comparable as an Indian medtech peer building indigenous products for hospital and diagnostic segments.
Emerging players
- Quanta Dialysis Technologies: UK-based company commercialising a compact, easy-to-use hemodialysis system (SC+) aimed at expanding dialysis into more care settings. Comparable to Renalyx as a technology-focused challenger aiming to broaden dialysis access beyond traditional centres.
- Outset Medical: US-based developer of the Tablo Hemodialysis System — an enterprise-grade connected hemodialysis platform designed for clinic and hospital use with cloud connectivity. Most directly comparable tech/digital-native peer to Renalyx's RxT21 + Digital Nephrology Platform vision.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Renalyx Health Systems social profiles
Digital presenceRenalyx Health Systems compliance and trust
Trust signalCompliance4 records
Renalyx Health Systems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Renalyx Health Systems leadership team
Management profileNumber of profiles
Profiles23 records
Renalyx Health Systems funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Renalyx Health Systems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Renalyx Health Systems
What does Renalyx Health Systems do?
Renalyx Health Systems designs, develops and manufactures indigenous hemodialysis machines (RxT17 and RxT21) along with a cloud-based Digital Nephrology Platform and the ReachnCare point-of-care CKD early detection system. The company provides an end-to-end renal care solution spanning early Chronic Kidney Disease detection, dialysis treatment for ESRD and ICU patients, and remote patient monitoring by qualified nephrologists.
Is Renalyx Health Systems a public or private company?
Renalyx Health Systems is a private company. It is classified as corporate owned and is currently operating.
When was Renalyx Health Systems founded?
Renalyx Health Systems was founded in 2012. It employs 11 to 50 people.
Where is Renalyx Health Systems based?
Renalyx Health Systems is headquartered in Bengaluru, India, in the Asia region.
How does Renalyx Health Systems make money?
Three revenue lines are on record. Medical Device Sales are the primary driver. The others are software/Subscription Services and consumables.
Who are Renalyx Health Systems's main competitors?
Broad incumbents on record are DaVita, Fresenius Medical Care, B. Braun Avitum, Asahi Kasei Medical, Nipro Corporation and Baxter International (Vantive / Kidney Care). Regional players are BPL Medical Technologies and Trivitron Healthcare. Emerging players are Quanta Dialysis Technologies and Outset Medical.
Does Renalyx Health Systems have an API?
No public API is recorded for Renalyx Health Systems.
What industry is Renalyx Health Systems in?
Renalyx Health Systems's product category is Hemodialysis Medical Devices. Its primary akta.pro industry code is HLAHAKAA, Hemodialysis Machines & Systems, with a secondary code of HLAHAKAJ, Renal Diagnostics & Monitoring (eGFR/Creatinine POC, Urine Analyzers, BP/Fluid Status). Its SIC code is 3841.